Cerecor Regains Compliance with NASDAQ Minimum Bid Price Requirement

Pharmaceutical Investing

Cerecor announced it regained its compliance with the NASDAQ stock listing.

Cerecor (NASDAQ:CERC) announced it regained its compliance with the NASDAQ stock listing.
As quoted in the press release:

Cerecor… received a letter from the Nasdaq Listing Qualifications Staff (the “Staff“) confirming that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the “Rule“) for continued listing on The Nasdaq Capital Market. In February 2017, the Staff notified the Company that its common stock failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days as required by the Rule.

Click here to read the full press release.

Source: www.marketwired.com

The Conversation (0)
×